怀孕中的抗脂综合征:一个全面的文献综述
Viorela Romina Murvai1,2, Radu Galiș3, Anca Panaitescu4
1Doctoral School of Biological and Biomedical Sciences, Bihor County Emergency Clinical Hospital, University of Oradea, Oradea, 410087, Romania.
怀孕期间的抗脂综合征 (APS) 显著增加了不良结果的风险. 目前的治疗方法,如低剂量阿司匹林和肝素,可以提高活产率,新兴疗法显示出有前途.
科学领域:
- 产科和妇科 产科和妇科
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 抗脂综合征 (APS) 是一种与血栓形成和不良妊娠结果相关的自身免疫性疾病,影响0.5%的人口.
- 产科性APS (OAPS) 是导致重复流产,子宫前和胎儿生长受限的主要原因.
- 怀孕期间APS的最佳管理需要对当前证据进行系统的评估.
研究的目的:
- 综合有关APS病原体,诊断标准和产科环境中的治疗干预措施的证据.
- 专注于产科抗脂综合征 (OAPS) 的母亲和胎儿结果.
- 为了评估当前的APS在怀孕期间的治疗策略.
主要方法:
- 我们对PubMed进行了全面的文献搜索.
- 纳入标准优先考虑随机对照试验,队列研究和专注于APS和怀孕的系统审查.
- 研究探讨了APS的发病性,诊断标准,以及在产科环境中的治疗疗效.
主要成果:
- APS的发病包括一个"双击"模型:抗脂抗体 (aPLs) 引起内皮损伤,导致血栓形成和胎盘缺陷.
- 狼抗凝剂 (LA) 是OAPS中不良结果的关键预测因素.
- 低剂量阿司匹林 (LDA) 和肝素减少流产; 氧化 (HCQ) 提高活产率并减少早产; 新型疗法正在出现.
结论:
- APS是不良妊娠结果的关键因素,需要精确的诊断和量身定制的管理.
- 在OAPS中,个性化治疗方案对于优化孕产妇和胎儿健康至关重要.
- 对新型药理学方法的进一步研究对于完善治疗方案和临床指南至关重要.
更多相关视频
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
相关概念视频
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Development of the Oral Microbiota
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Chronic Pancreatitis I: Introduction
